As of Aug 23
| +0.06 / +1.02%|
The 11 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 22.00, with a high estimate of 36.00 and a low estimate of 7.00. The median estimate represents a +269.75% increase from the last price of 5.95.
The current consensus among 12 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.